EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Early- vs. late-onset colon cancer: clinicopathological insights and survival outcomes in an East Asian cohort

Chun-Chi Lin, Che-Yuan Chang, Yu-Zu Lin, Hou-Hsuan Cheng, Sheng-Chieh Huang, Hung-Hsin Lin, Yuan-Tzu Lan, Huann-Sheng Wang, Shih-Ching Chang, Shung-Haur Yang, Jeng-Kai Jiang, Wei-Shone Chen, Hao-Wei Teng, Yi-Wen Yang

International Journal of Colorectal Disease · 2025-10-09 · 40 (1)

DOI: 10.1007/s00384-025-05007-4 ↗
AbstractBibliografische Angaben

Abstract

Abstract Purpose Colorectal cancer (CRC) is the third most prevalent cancer worldwide, showing an increasing early-onset CRC in patients, which is defined as diagnoses made before the age of 50. Studies conflict on early-onset CRC prognosis versus late-onset CRC with varying survival outcomes. This study explores the age-related survival differences in colon cancer by comparing early- and late-onset groups. Methods We performed a retrospective cohort study at a tertiary referral hospital (2010–2018), including 3459 patients with colon cancer (3076 late-onset, 383 early-onset). The clinicopathological features of early- and late-onset colon cancer were compared, and cancer-specific survival was evaluated using the Kaplan–Meier analysis with log-rank tests. The multivariate Cox regression identified independent prognostic factors. Results Early-onset colon cancer showed female predominance, better Eastern Cooperative Oncology Group performance, more left-sided tumors, and advanced stages. On the contrary, late-onset patients had worse cancer-specific survival (hazard ratio 1.506, 95% confidence interval 1.147–1.977, p = 0.003), particularly in stages II/III, with tumor perforation, signet ring cells, or no perineural invasion. Conclusion In conclusion, despite early-onset colon cancer exhibiting more aggressive features, it is associated with better survival compared with late-onset cases. Further studies are required to validate these findings.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →